mLabs latest Tonometer was designed to consider all the different environments clinicians face all over the world. The long-lasting battery, compact design and the portability of the device enables it to be used in a small practice room, domiciliary use or even large scale screening programs. However, our key targets which we believe will play a pivotal role in increasing detection rates of Glaucoma were: –
Accuracy:
The Tonocare has been through a rigorous testing protocol to compare closely to GAT. The heavy investment into the dynamic puff control enable the tonometer to produce accurate and consistent measurements which in turn will enable users to confidently monitor changes in IOP over time.
Affordability:
Our aim was to ensure all clinicians all over the world could afford to use the device with little burdening costs on either their practice or the patient, inherently this would ensure detection of the second leading cause blindness to increase.
